Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a localised prostate cancer (a type called adenocarcinoma) and have already had their prostate removed as a curative treatment.
- People whose PSA blood test result is between 0.1 and less than 0.5 ng/ml (a measure of a protein that can indicate prostate cancer activity).
Who may not be able to join:
- People who are planned to receive an x-ray contrast dye or another type of PET imaging tracer less than 24 hours before the specific scan used in this trial (called a flotufolastat F-18 PSMA-PET scan).
- People who are currently receiving a hormone-based treatment known as Androgen Deprivation Therapy (ADT), which works by lowering certain hormone levels in the body.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 407-303-2090
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cancer Detection Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.